The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
暂无分享,去创建一个
R. Cortese | A. Nicosia | R. Roccasecca | G. Filocamo | R. Cerino | E. Scarselli | H. Ansuini | S. Acali | C. Traboni | A. Vitelli | Riccardo Cortese | Elisa Scarselli | Cinzia Traboni | Alessandra Vitelli | Alfredo Nicosia | Helenia Ansuini | Raffaele Cerino | Rosa Maria Roccasecca | Stefano Acali | Gessica Filocamo
[1] F. G. van der Goot,et al. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. , 2001, Seminars in immunology.
[2] K. Meyer,et al. Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients. , 2002, The Journal of infectious diseases.
[3] Sobolev,et al. Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions , 2000, Journal of viral hepatitis.
[4] A. Oppenheim,et al. Caveolar Endocytosis of Simian Virus 40 Is Followed by Brefeldin A-Sensitive Transport to the Endoplasmic Reticulum, Where the Virus Disassembles , 2002, Journal of Virology.
[5] M. Vega,et al. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. , 1993, The Journal of biological chemistry.
[6] D. Gómez-Coronado,et al. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[7] M. Houghton,et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] V. Agnello,et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Ishii,et al. Characterization of pseudotype VSV possessing HCV envelope proteins. , 2001, Virology.
[10] T. Gojobori,et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization , 1998, Archives of Virology.
[11] A. Meola,et al. Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection , 2000, Journal of Virology.
[12] C. Enrich,et al. Biochemical analysis of a caveolae‐enriched plasma membrane fraction from rat liver , 2000, Electrophoresis.
[13] M. Mondelli,et al. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients , 1995, Journal of virology.
[14] W. J. Johnson,et al. Cellular Cholesterol Efflux Mediated by Cyclodextrins , 1996, The Journal of Biological Chemistry.
[15] J. Hoofnagle,et al. Therapy of Hepatitis C , 1995, Seminars in liver disease.
[16] A Cerino,et al. Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? , 2001, Antiviral research.
[17] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Lodish,et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.
[19] S. Emerson,et al. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Tall,et al. High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* , 2001, The Journal of Biological Chemistry.
[21] K. Okita,et al. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization , 2001, Journal of viral hepatitis.
[22] M. Houghton,et al. Binding of hepatitis C virus to CD81. , 1998, Science.
[23] A. Weiner,et al. Vaccination of chimpanzees against infection by the hepatitis C virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Alter,et al. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.
[25] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[26] R. Bartenschlager,et al. Novel cell culture systems for the hepatitis C virus. , 2001, Antiviral research.
[27] Richard G. W. Anderson,et al. Murine SR-BI, a High Density Lipoprotein Receptor That Mediates Selective Lipid Uptake, Is N-Glycosylated and Fatty Acylated and Colocalizes with Plasma Membrane Caveolae* , 1997, The Journal of Biological Chemistry.
[28] S. Emerson,et al. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. , 2000, Virology.
[29] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Goldsmith,et al. Association of the Caveola Vesicular System with Cellular Entry by Filoviruses , 2002, Journal of Virology.
[31] M. Krieger,et al. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. , 2001, The Journal of clinical investigation.
[32] W. J. Johnson,et al. Cellular Cholesterol Efflux Mediated by Cyclodextrins (*) , 1995, The Journal of Biological Chemistry.
[33] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[34] Anna Tramontano,et al. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants , 1998, The EMBO journal.
[35] M. Houghton,et al. Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding , 2000, Journal of virology.
[36] G. Deléage,et al. Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment , 2001, Journal of Virology.
[37] Anna Tramontano,et al. A model for the hepatitis C virus envelope glycoprotein E2 , 2000, Proteins.
[38] R. Silverstein,et al. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.
[39] J. Dubuisson,et al. Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 , 1999, Journal of Virology.
[40] N. Kato,et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.
[41] T. Liang,et al. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. , 2002, Virology.
[42] A. Weiner,et al. Sequence variation in hepatitis C viral isolates. , 1991, Journal of hepatology.
[43] A. Meola,et al. Monoclonal Antibodies with Broad Specificity for Hepatitis C Virus Hypervariable Region 1 Variants Can Recognize Viral Particles1 , 2001, The Journal of Immunology.
[44] M. Esumi,et al. Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. , 2000, Virology.
[45] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[46] J. Bergelson,et al. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Martínez-A,et al. Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.
[48] T. Kähne,et al. Non-radioactive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. , 1994, Journal of immunological methods.
[49] Arvind H. Patel,et al. Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles , 2002, Journal of Virology.
[50] L. Seeff,et al. Hepatitis C: a brief clinical overview. , 2001, ILAR journal.
[51] P. Borrow,et al. Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 Glycoprotein , 2000, Journal of Virology.